BioCentury
ARTICLE | Clinical News

ImmuRAID-AFP antibody fragment targeted to alpha fetal protein data

June 13, 1994 7:00 AM UTC

In an investigator-initiated trial in 45 patients with a total of 169 tumor sites, the agent gave 75 percent specificity, 99 percent sensitivity, and 90 percent accuracy. No side effects or HAMA respo...